Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Immunotherapy
|
September 5, 2014
Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?
Michael P Pender, Rajiv Khanna
European Neurology
|
July 15, 2005
Multiple sclerosis with idiopathic dilated cardiomyopathy: a case report
Annabelle N Sellbach, Michael P Pender
Journal of Autoimmunity
|
May 27, 2008
Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis
Judith M Greer, Michael P Pender
Clinical & Translational Immunology
|
December 16, 2014
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Michael P Pender, Scott R Burrows
Neurology
|
February 16, 2006
Lower motor neuron weakness after diving-related decompression
Robert D Henderson, Michael P Pender
Current Allergy and Asthma Reports
|
June 6, 2007
Immunology of multiple sclerosis
Michael P Pender, Judith M Greer
Frontiers in Immunology
|
September 25, 2020
Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types
Judith M Greer, Elisabeth Trifilieff, Michael P Pender
Frontiers in Immunology
|
May 24, 2017
Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease
Judith M Greer, Simon Broadley, Michael P Pender
Journal of Neuroimmunology
|
April 4, 1998
The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis
Catherine A White, Pamela A McCombe, Michael P Pender
Journal of Neuroimmunology
|
February 16, 2005
Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement
Diane M Muller, Michael P Pender, Judith M Greer
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Immunotherapy
|
September 5, 2014
Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?
Michael P Pender, Rajiv Khanna
European Neurology
|
July 15, 2005
Multiple sclerosis with idiopathic dilated cardiomyopathy: a case report
Annabelle N Sellbach, Michael P Pender
Journal of Autoimmunity
|
May 27, 2008
Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis
Judith M Greer, Michael P Pender
Clinical & Translational Immunology
|
December 16, 2014
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Michael P Pender, Scott R Burrows
Neurology
|
February 16, 2006
Lower motor neuron weakness after diving-related decompression
Robert D Henderson, Michael P Pender
Current Allergy and Asthma Reports
|
June 6, 2007
Immunology of multiple sclerosis
Michael P Pender, Judith M Greer
Frontiers in Immunology
|
September 25, 2020
Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types
Judith M Greer, Elisabeth Trifilieff, Michael P Pender
Frontiers in Immunology
|
May 24, 2017
Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease
Judith M Greer, Simon Broadley, Michael P Pender
Journal of Neuroimmunology
|
April 4, 1998
The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis
Catherine A White, Pamela A McCombe, Michael P Pender
Journal of Neuroimmunology
|
February 16, 2005
Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement
Diane M Muller, Michael P Pender, Judith M Greer
Page
of 7